DBV stock rallies post-market on FDA Viaskin update (NASDAQ:DBVT)


DBV stock rallies post-market on FDA Viaskin update (NASDAQ:DBVT)

Professor25/iStock via Getty Images

  • DBV Technologies (NASDAQ:DBVT) stock shot up 29% in post-market trading Wednesday after the company said it has aligned with the FDA on an accelerated approval pathway for its peanut allergy patch Viaskin for children aged one to three years.
  • The



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

How Hezbollah’s losses have weakened Iran

How Hezbollah's losses have weakened Iran - CBS News ...

Gold Rate Today In India: Check 22 Carat Price In Your City On December 23

Last Updated:December 23, 2024, 09:29 ISTGold Rate Today In India: Check 22 and 24 carat gold prices in different cities on December 23, 2024Check...

Follow us

653FansLike
201FollowersFollow
467SubscribersSubscribe

Most Popular